StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.29−0.14 (-0.88%)

Close on Nov 17, 2026Market cap $82.32MP/E 3.4Yield –

Rallybio enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Rallybio's enterprise value was -$8.95M on Nov 11, 2026, against -$32.00M a year earlier. Over the last 5 years it ranged from -$70.37M to $317.54M, with a median of -$8.95M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$8.95M–
2025Dec 31, 2025-$30.53M–
2024Dec 31, 2024-$35.27M–
2023Dec 29, 2023-$31.06M-139.6%
2022Dec 30, 2022$78.44M-34.4%
2021Dec 31, 2021$119.54M–

More Rallybio figures

See a number that looks wrong?